JNANA IS EXPANDING THE BOUNDARIES OF DRUG DISCOVERY BY OPENING SLC TRANSPORTERS AS A THERAPEUTIC TARGET CLASS.
SLC transporters:
Gateways to treat disease
SLC transporters are the cellular gates that control the movement of hundreds of metabolites, the chemical building blocks and nutrients essential for life.
RAPID Platform
We have built the first drug discovery platform that targets SLC transporters, overcoming the myriad of challenges for addressing this target class.
WE ARE COMMITTED TO DEVELOPING BEST-IN-CLASS THERAPEUTICS FOR PATIENTS WITH HIGH UNMET NEED
OUR TEAM AND COLLABORATIVE CULTURE ARE FOUNDATIONAL
Jnana values the unique perspectives and contributions of each member of our team.
